Article in Medical sciences (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Elisa García-MartínezBasic Research Subdirection, National Cancer Institute of Mexico (INCan), Mexico City 14080, Mexico.ORCID 0000-0003-3372-741X
Leonardo S Lino-SilvaDepartment of Pathology, National Cancer Institute of Mexico (INCan), Mexico City 14080, Mexico.ORCID 0000-0002-7394-5123
Adriana Romo-PérezInstitute of Chemistry, National Autonomous University of Mexico, Mexico City 04510, Mexico.ORCID 0000-0003-3985-0101
Leticia Bornstein-QuevedoInmunoQ, Laboratorio de Patología, Inmunohistoquímica y Biología Molecular, Mexico City 03100, Mexico.
Alma Chavez-BlancoBasic Research Subdirection, National Cancer Institute of Mexico (INCan), Mexico City 14080, Mexico.ORCID 0000-0002-4201-5935
Guadalupe Dominguez-GomezBasic Research Subdirection, National Cancer Institute of Mexico (INCan), Mexico City 14080, Mexico.
Horacio N Lopez-BasaveDepartment of Gastroenterology, National Cancer Institute of Mexico (INCan), Mexico City 14080, Mexico.
Alejandro Padilla-RoscianoDepartment of Gastroenterology, National Cancer Institute of Mexico (INCan), Mexico City 14080, Mexico.
Consuelo Diaz-RomeroDepartment of Medical Oncology, National Cancer Institute of Mexico (INCan), Mexico City 14080, Mexico.
Aurora Gonzalez-FierroBasic Research Subdirection, National Cancer Institute of Mexico (INCan), Mexico City 14080, Mexico.
Alfonso Duenas-GonzalezDirection of Teaching and Research, Maternal and Child Institute of the State of Mexico (IMIEM), Toluca 50170, Mexico.ORCID 0000-0002-2956-645X
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Expression of Hexokinase-2 (HK2), Glutaminase-1 (GLS1) and Fatty Acid Synthase (FASN) in Gastric Cancer and Their Prognostic Significance. · full record | OpenQuestion